Angels righty Griffin Canning will receive “biological injections” to treat his ailing elbow, the team announced and MLB.com’s Rhett Bollinger was among those to cover on Twitter. The team says he’ll be “reassessed in three to four weeks.”
This news still leaves some mystery as to the underlying condition and to Canning’s outlook. But it confirms that he’ll be sidelined for a lengthy stretch, as had already become clear of late.
Clearly there’s still hope of avoiding an invasive procedure. But the Halos will assuredly need to bring Canning along cautiously even if these injections prove effective. It’ll be hard for the team to presume much of anything about his availability in 2020.
Canning had a strong debut showing in 2019 but ended the season earlier with elbow woes. Unfortunately, they followed him into camp.
While the Halos did add two notable arms to their rotation, trading for Dylan Bundy and signing Julio Teheran, the rotation remains an area of weakness on paper. The Angels do have some options on hand, but they’ll need a few hurlers to establish or reestablish themselves as quality big league starters. For what it’s worth, they’ve shown well collectively to this point in camp, as Jeff Fletcher of the Orange County Register notes on Twitter.